May I ask how, in your opinion, MSB should have gone about getting an appropriate historical control in a heteogeneous condition that's not particularly common and targeting a subset of that, a condition where grading and assessment have been historically subjective and unreliable?
Also, may I ask what Incyte used for their historical control that resulted in FDA approval in a similar single-arm trial?
- Forums
- ASX - By Stock
- AFR reports that the co to be sued for its promotional announcements.
MSB
mesoblast limited
Add to My Watchlist
5.29%
!
$1.79

May I ask how, in your opinion, MSB should have gone about...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
0.090(5.29%) |
Mkt cap ! $2.287B |
Open | High | Low | Value | Volume |
$1.73 | $1.81 | $1.72 | $8.254M | 4.665M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5313 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.81 | 12938 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5313 | 1.790 |
3 | 225090 | 1.780 |
2 | 50000 | 1.770 |
2 | 8500 | 1.750 |
2 | 12025 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.810 | 12938 | 4 |
1.820 | 1800 | 2 |
1.850 | 16600 | 3 |
1.860 | 3000 | 1 |
1.880 | 9800 | 3 |
Last trade - 16.10pm 25/04/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |